VRG-50635

N/A

Report date: 2022/11/01 10:21:12
NME

Base Information

Drug NameVRG-50635
Drug Alias NameVRG-50635
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action1-phosphatidylinositol 3-phosphate 5-kinase inhibitors
Targets1-phosphatidylinositol 3-phosphate 5-kinase
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVerge Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFerrerVerge Genomics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A